Search
Aligos Therapeutics Inc
ALGSAdd to Watchlist
4.230USD
-0.090-2.08%
Close 07-31 16:00（ET）Quotes delayed by 15 min
26.18MMarket Cap
LossP/E TTM
Aligos Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Aligos Therapeutics Inc is 8.75, ranking 62 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.43, which is -31.58% below the recent high of -0.30 and -1263.72% above the recent low of -5.89.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.